Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falsetruefalsefalse2023-12-12No description of principal activity1 OC450274 2023-12-11 OC450274 2023-12-12 2024-12-31 OC450274 2023-01-01 2023-12-11 OC450274 2024-12-31 OC450274 c:CurrentFinancialInstruments 2024-12-31 OC450274 c:CurrentFinancialInstruments 2 2024-12-31 OC450274 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 OC450274 e:FRS102 2023-12-12 2024-12-31 OC450274 e:AuditExemptWithAccountantsReport 2023-12-12 2024-12-31 OC450274 e:FullAccounts 2023-12-12 2024-12-31 OC450274 e:LimitedLiabilityPartnershipLLP 2023-12-12 2024-12-31 OC450274 2 2023-12-12 2024-12-31 OC450274 6 2023-12-12 2024-12-31 OC450274 e:PartnerLLP1 2023-12-12 2024-12-31 OC450274 e:PartnerLLP2 2023-12-12 2024-12-31 OC450274 c:OtherCapitalInstrumentsClassifiedAsEquity 2024-12-31 OC450274 c:FurtherSpecificReserve2ComponentTotalEquity 2024-12-31 OC450274 f:PoundSterling 2023-12-12 2024-12-31 iso4217:GBP xbrli:pure

Registered number: OC450274










ASI LONDON L CLINICIAN LLP








UNAUDITED

FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 DECEMBER 2024

 
ASI LONDON L CLINICIAN LLP
 

INFORMATION




Designated Members

ASI Welbeck Holdings Limited (appointed 12 December 2023)
Andrew Hutton (appointed 12 December 2023)

LLP registered number

OC450274

Registered office

1 Welbeck StreetLondonW1G 0AR

Accountants

MHAVictoria Court17-21 Ashford RoadMaidstoneME14 5DA


 
ASI LONDON L CLINICIAN LLP
 

CONTENTS



Page
Members' Report
 
 
1 - 2
Accountants' Report
 
 
3
Statement of Comprehensive Income
 
 
4
Balance Sheet
 
 
5 - 6
Reconciliation of Members' Interests
 
 
7
Notes to the Financial Statements
 
 
8 - 11


 
ASI LONDON L CLINICIAN LLP
 
  
MEMBERS' REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2024

The members present their annual report together with the financial statements of ASI London L Clinician LLP (the "LLP") for the period ended 31 December 2024
 

Principal activities
 
 
The LLP was incorporated on 12 December 2023 and commenced trading on that date.
 
 
The principal object of the LLP is that of investing activities. 
 
 
Designated Members
 
 
ASI Welbeck Holdings Limited and Andrew Hutton were designated members of the LLP throughout the period.
 

 
Members' capital and interests
 
 
Each member's subscription to the capital of the LLP is determined by their share of the profit and is repayable following retirement from the LLP.
 
 
Details of changes in members' capital in the period ended 31 December 2024 are set out in the Reconciliation of Members' Interests.
 
 
Members are remunerated from the profits of the LLP and are required to make their own provision for pensions and other benefits. Profits are allocated and divided between members after finalisation of the financial statements. Members draw a proportion of their profit shares monthly during the year in which it is made, with the balance of profits being distributed after the year, subject to the cash requirements of the business.
 

Members' responsibilities statement
 
 
The members are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
 
 
Company law, (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008), requires the members to prepare financial statements for each financial year. Under that law the members have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) the members must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the LLP and of the profit or loss of the LLP for that period.

In preparing these financial statements, the members are required to:
 
select suitable accounting policies and then apply them consistently;
 
make judgements and accounting estimates that are reasonable and prudent;
 
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the LLP will continue in business.
 

Page 1

 
ASI LONDON L CLINICIAN LLP
 
 
MEMBERS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
 
 
The members are responsible for keeping adequate accounting records that are sufficient to show and explain the LLP's transactions and disclose with reasonable accuracy at any time the financial position of the LLP and to enable them to ensure that the financial statements comply with the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of the Companies Act 2006) Regulations 2008)They are also responsible for safeguarding the assets of the LLP and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
 
This report was approved by the members and signed on their behalf by: 




Andrew Hutton
Designated member



Date: 25 September 2025

25 September 2025
Page 2

 
ASI LONDON L CLINICIAN LLP
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE MEMBERS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ASI LONDON L CLINICIAN LLP
FOR THE PERIOD ENDED 31 DECEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008), we have prepared for your approval the financial statements of ASI London L Clinician LLP for the period ended 31 December 2024 which comprise the Statement of Comprehensive Income, the Balance Sheet and the related notes from the LLP's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the members in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of ASI London L Clinician LLP and state those matters that we have agreed to state to the ASI London L Clinician LLP's members in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ASI London L Clinician LLP and its members for our work or for this report. 

It is your duty to ensure that ASI London L Clinician LLP has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of ASI London L Clinician LLP. You consider that ASI London L Clinician LLP is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or review of the financial statements of ASI London L Clinician LLP. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



MHA
Chartered Accountants
Victoria Court
17-21 Ashford Road
Maidstone
ME14 5DA
30 September 2025
Page 3

 
ASI LONDON L CLINICIAN LLP
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31 DECEMBER 2024

31 December
2024
£

  

Administrative expenses
  
(2,342)

Operating loss
  
 
(2,342)

Income from fixed assets investments
  
59,888

Interest receivable and similar income
  
6,297

Profit before tax
  
 
63,843

Profit for the period before members' remuneration and profit shares available for discretionary division among members
  
 
63,843

There were no recognised gains and losses for 2024 other than those included in the statement of comprehensive income.

There was no other comprehensive income for 2024.

The notes on pages 8 to 11 form part of these financial statements.

Page 4

 
ASI LONDON L CLINICIAN LLP
REGISTERED NUMBER: OC450274

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
Note
£

Fixed assets
  

Investments
 5 
433,776

Current assets
  

Debtors: amounts falling due within one year
 6 
307,247

Cash at bank and in hand
  
200

  
307,447

Creditors: Amounts Falling Due Within One Year
 7 
(2,380)

Net current assets
  
 
 
305,067

Total assets less current liabilities
  
738,843

  

Net assets
  
738,843


Represented by:
  

Loans and other debts due to members within one year
  

Members' other interests
  

Members' capital classified as equity
  
675,000

Other reserves classified as equity
  
63,843

  
 
738,843

  
738,843


Total members' interests
  

Amounts due from members (included in debtors)
  
(101,327)

Members' other interests
  
738,843

  
637,516


Page 5

 
ASI LONDON L CLINICIAN LLP
REGISTERED NUMBER: OC450274
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements were approved and authorised for issue by the members and were signed on their behalf on 25 September 2025.




Andrew Hutton
Designated member

The notes on pages 8 to 11 form part of these financial statements.

ASI London L Clinician LLP has no equity and, in accordance with the provisions contained within the Statement of Recommended Practice "Accounting by Limited Liability Partnerships", has not presented a Statement of Changes in Equity.

Page 6

 
ASI LONDON L CLINICIAN LLP
 

RECONCILIATION OF MEMBERS' INTERESTS
FOR THE PERIOD ENDED 31 DECEMBER 2024







EQUITY
Members' other interests
DEBT
Loans and other debts due to members less any amounts due from members in debtors
Total members' interests
Members' capital (classified as equity)
Other reserves
Total
Other amounts
Total
Total

£
£
£
£
£
£

At Incorporation
-
-
-
-
-
-

Profit for the period available for discretionary division among members
 
-
63,843
63,843
-
-
63,843

Members' interests after profit for the period
-
63,843
63,843
-
-
63,843

Amounts introduced by members
675,000
-
675,000
-
-
675,000

Drawings on account and distribution of profit
-
-
-
(101,327)
(101,327)
(101,327)

Amounts due from members
 



(101,327)
(101,327)


Balance at 31 December 2024 
675,000
63,843
738,843
(101,327)
(101,327)
637,516

There are no existing restrictions or limitations which impact the ability of the members of the LLP to reduce the amount of Members' other interests.

Page 7

 
ASI LONDON L CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

1.


General information

ASI London L Clinician LLP is a Limited Liability Partnership incorporated in England and Wales in the United Kingdom. The address of the registered office is 1 Welbeck Street, London, W1G 0AR. 
These financial statements cover the period commencing on 12 December 2023 to the listed period end date, a period longer than 12 months, to bring the accounting period end date in line with associated organisations. 
The financial statements are presented in sterling which is the functional currency of the LLP and rounded to the nearest £1. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the LLP's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.3

Division and distribution of profits

A division of profits is the mechanism by which the profits of an LLP become a debt due to members. A division may be automatic or discretionary, may relate to some or all of the profits for a financial period and may take place during or after the end of a financial period.

An automatic division of profits is one where the LLP does not have an unconditional right to avoid making a division of an amount of profits based on the members' agreement in force at the time, whereas a discretionary division of profits requires a decision to be made by the LLP, which it has the unconditional right to avoid making.

The LLP divides profits discretionarily. Discretionary divisions of profits are recognised as amounts due to members, although may be used to offset amounts which have been drawn by members, which are recognised as loan assets repayable.

 
2.4

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Page 8

 
ASI LONDON L CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Financial instruments

The LLP has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the LLP's Balance Sheet when the LLP becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The LLP's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the LLP after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Page 9

 
ASI LONDON L CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.8
Financial instruments (continued)

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

No significant judgements have been made by management in preparing these financial statements, other than those disclosed in note 2 above. 


4.


Employees

The average monthly number of employees during the period was 0.


5.


Fixed asset investments





Other fixed asset investments

£



Cost or valuation


Additions
433,776



At 31 December 2024
433,776




Page 10

 
ASI LONDON L CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

6.


Debtors

2024
£


Other debtors
205,920

Amounts due from members
101,327

307,247



7.


Creditors: Amounts falling due within one year

2024
£

Other creditors
100

Accruals and deferred income
2,280

2,380


Page 11